DxS Ltd announces it is working closely with AstraZeneca to make available a companion diagnostic for use with IRESSA (gefitinib), AstraZenecas treatment for non small cell lung cancer (NSCLC).
Read MoreAbbott and GlaxoSmithKline (GSK) will develop an automated molecular diagnostic test intended to screen non-small cell lung cancer (NSCLC) tumors for expression of the MAGE-A3 antigen.
Read MoreAMDL Inc a US-based pharmaceutical company with major operations in China, announced today the launch of a new brand name for its DR-70 (FDP) in vitro diagnostic cancer test. With today’s announcement, AMDL will manufacture, market, and sell DR-70 under the brand name Onko-Sure.
Read More
LabCorp Enters Definitive Agreement to Acquire Monogram Biosciences Laboratory Corp of America® Holdings (LabCorp) and Monogram Biosciences Inc announced recently that they have entered into a definitive agreement and plan of merger under which
Read More
Pharmacogenetics has the potential to avoid some of the three quarter million adverse drug events seen each year.
Read More